Change over period
From:
To:
Zoom:
- 1Y
- 3Y
- 5Y
- 10Y
- 15Y
- 20Y
- Max
TherapeuticsMD Inc
NASDAQ TXMD
Data sourced from
and
and
TherapeuticsMD Inc Net Debt for the quarter ending March 31, 2024
TherapeuticsMD Inc Net Debt is NA for the quarter ending March 31, 2024. Net Debt is the difference between a company's total debt and its cash and cash equivalents.
-
TherapeuticsMD Inc Net Debt for the quarter ending March 31, 2021 was USD 321.59 M, a -22.56% change year over year.
-
TherapeuticsMD Inc Net Debt for the quarter ending March 31, 2020 was USD 415.28 M, a 110.22% change year over year.
Don’t Miss A Beat
Looking to stay ahead of the competition and stay informed? Receive your daily dose of market news, trends, and analysis to kickstart your day and stay up-to-date.
NASDAQ: TXMD
| CEO | Governor Thomas G. Thompson |
| IPO Date | Dec. 11, 2003 |
| Location | United States |
| Headquarters | 951 Yamato Road, Boca Raton, FL, United States, 33431 |
| Employees | 1 |
| Sector | Healthcare |
| Industry | Drug manufacturers - specialty & generic |
Description
TherapeuticsMD, Inc. operates as a pharmaceutical royalty company in the United States. It has a license agreement with Mayne Pharma to commercialize the IMVEXXY, BIJUVA, and ANNOVERA prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brand names. The company sells its prescription pharmaceutical products and prenatal vitamin products through wholesale distributors and retail pharmacy distributors. TherapeuticsMD, Inc. was founded in 2008 and is headquartered in Boca Raton, Florida.
Key trends
Similar companies
Eagle Pharmaceuticals Inc
NA
NA
Cyclo Therapeutics Inc
NA
NA
StockViz Staff
September 20, 2024
Any question? Send us an email